蒙牛/現代牧業/原生態牧業依次漲近6%-21%齊探頂 惟飛鶴逆吐逾4%
乳業股普遍受捧,藍籌蒙牛(02319.HK)突破上月中旬所創上市高位42.65元,報43.05元,漲近5.8%,成交有1,281萬股。現代牧業(01117.HK)急漲11%報1.54元創近兩年半高,成交急增至5,781萬股。
今年9月初獲中國飛鶴(06186.HK)建議溢價以每股0.63元提購的原生態牧業(01431.HK)於高位橫行三個月後,午後股價突呈異動,升破9月初所創52周高位0.66元,最高見0.79元,現造0.76元,急漲近21%,成交急增至3,962萬股,涉資2,800萬元。不過,飛鶴回吐4.2%報17.9元,曾失守10天線低見17.7元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.